Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Sailesh Raj Bhan, Kinjal Desai. The fund could potentially beat inflation in the long-run.
Expense ratio | 0.92% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹7125 Cr |
Inception Date | 1 January, 2013 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1% |
Lock In | No Lock-in |
TurnOver | 18.67% |
Size breakup
Nippon India Pharma Fund - Direct Plan - Growth Plan | Absolute Returns | CAGR Returns |
1 Month Returns | 0.37% | 0.37% |
6 Month Returns | 26.51% | 26.51% |
1 Year Returns | 53.06% | 53.06% |
3 Years Returns | 61.9% | 17.42% |
5 Years Returns | 191.21% | 23.83% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 1.65 | 2.21 | 4.22 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 0.94 | 0.95 | 0.92 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 2.95 | 0.96 | 0.99 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 14.24 | 15.52 | 18.6 |